List of accepted Abstract
| Apply No. |
Category | Title | Presenting Author |
oral Time | Final No. |
|---|---|---|---|---|---|
| FP-0048 | Basic & Translational Research / Biology / Pathology | TUMOR SPREAD THROUGH AIR SPACES (STAS): PROGNOSTIC SIGNIFICANCE OF GRADING IN NON-SMALL CELL LUNG CANCER : CAN STAS BE A T FACTOR IN LUNG ADENOCARCINOMA? | Yeon Bi Han | 10:50~11:00 | OP1-01 |
| FP-0055 | Basic & Translational Research / Biology / Pathology | BALF LIQUID BIOPSY PROVIDES A NOVEL PLATFORM FOR SPEEDY AND ACCURATE EGFR MUTATION TESTING IN ADVANCED NSCLC PATIENTS | In Ae Kim | 11:00~11:10 | OP1-02 |
| FP-0031 | Basic & Translational Research / Biology / Pathology | DECONSTRUCTING THE INTRA-TUMOR SUBCLONAL HETEROGENEITY, ALLEL-SPECIFIC HLA LOSS AND IMMUNE ESCAPE OF LUNG SYNCHRONOUS ADENOCARCINOMAS PRESENTING AS GROUND-GLASS NODULES USING WHOLE GENOME SEQUENCING | Yijiu Ren | 11:10~11:20 | OP1-03 |
| FP-0029 | Basic & Translational Research / Biology / Pathology | MMP1/9/10/11/15 AS POTENTIAL TARGETS AND MMP12/13/14/28 AS NEW BIOMARKERS FOR THE PROGNOSIS OF HUMAN LUNG CANCER | Yujie Deng | 11:20~11:30 | OP1-04 |
| FP-0070 | Chemotherapy / Targeted Therapy / Immunotherapy / Advanced NSCLC | EGFR ANALYSIS OF MULTIPLE LUNG CANCER: CLINICOPATHOLOGIC REVIEW | Hyunwoo Lee | 11:30~11:40 | OP1-05 |
| FP-0061 | Chemotherapy / Targeted Therapy / Immunotherapy / Advanced NSCLC | PREDICTING CLINICAL OUTCOMES IN LUNG CANCER PATIENTS AFTER IMMUNE CHECKPOINT INHIBITOR: A COMPARISON BETWEEN SEMIAUTOMATIC SOFTWARE AND RECIST | Jehun Kim | 11:40~11:50 | OP1-06 |
| FP-0062 | Chemotherapy / Targeted Therapy / Immunotherapy / Advanced NSCLC | COMPARISON OF EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITORS FOR PATIENTS WITH LUNG ADENOCARCINOMA HARBORING DIFFERENT EPIDERMAL GROWTH FACTOR RECEPTOR MUTATION TYPES | Sojung Park | 11:50~12:00 | OP1-07 |
| FP-0018 | Chemotherapy / Targeted Therapy / Immunotherapy / Advanced NSCLC | THE IMPACT OF PROGRAMMED DEATH-LIGAND 1 EXPRESSION ON THE PROGNOSIS OF EARLY-STAGE RESECTED NON-SMALL CELL LUNG CANCER: A META-ANALYSIS OF LITERATURES. | Shuai Zhu | 12:00~12:10 | OP1-08 |
| FP-0023 | Advanced NSCLC / Chemotherapy / Targeted Therapy / Immunotherapy | CIRCULATING TUMOR CELLS AND PERIPHERAL BLOOD CELLS AS PREDICTIVE MARKERS FOR IMMUNOTHERAPY IN ADVANCED NON-SMALL CELL LUNG CANCER | Cheol-Kyu Park | 12:10~12:20 | OP1-09 |
| FP-0028 | Advanced NSCLC / Chemotherapy / Targeted Therapy / Immunotherapy | FUNCTIONAL ROLE OF COMPOUND EGFR MUTATION AND ITS POTENTIAL PREDICTIVE VALUE ON ARCHIVAL TUMOR TISSUES OF THE LUNG ADENOCARCINOMA PATIENTS HARBORING EGFR MUTATIONS. | Seo Ree Kim | 12:20~12:30 | OP1-10 |
| FP-0037 | Early / Locally Advanced NSCLC | CT MEAN DENSITY IS ASSOCIATED WITH PATHOLOGICAL INVASION FOR PURE GROUND-GLASS NODULES | Jian Zhang | 12:40~12:50 | OP2-01 |
| FP-0032 | Early / Locally Advanced NSCLC | DEVELOPMENT AND VALIDATION OF MACHINE LEARNING-BASED MODEL FOR THE PREDICTION OF MALIGNANCY IN MULTIPLE PULMONARY NODULES: ANALYSIS FROM MULTICENTRIC COHORTS | Yuntao Nie | 12:50~13:00 | OP2-02 |
| FP-0045 | Radiology / Staging / Screening / Epidemiology | CORRELATION OF EGFR STATUS WITH CHEST CT SCAN FINDINGS AMONG PATIENTS WITH NON-SMALL CELL LUNG ADENOCARCINOMA: A SINGLE-CENTER RETROSPECTIVE COHORT STUDY | Jestoni Aranilla | 13:00~13:10 | OP2-03 |
| FP-0019 | Radiology / Staging / Screening / Epidemiology | LUNG CANCER PROBABILITY AND CLINICAL OUTCOMES OF BASELINE AND NEW SUBSOLID NODULES DETECTED ON LOW-DOSE COMPUTED TOMOGRAPHY SCREENING | Yeon Wook Kim | 13:10~13:20 | OP2-04 |
| FP-0069 | Radiology / Staging / Screening / Epidemiology | RADIOLOGIC AND CLINICAL FEATURES OF SCREENING-DETECTED PULMONARY INVASIVE MUCINOUS ADENOCARCINOMA | Dae Hyeon Kim | 13:20~13:30 | OP2-05 |
| FP-0020 | SCLC / Neuroendocrine Tumors | CHARACTERISTICS AND CLINICAL OUTCOMES OF PATIENTS WITH NON-SMOKING SMALL CELL LUNG CANCER IN KOREA | Hye Seon Kang | 13:30~13:40 | OP2-06 |
| FP-0064 | Mesothelioma / Thymic & Other Thoracic Malignancies | A NATIONAL ANALYSIS OF THE MANAGEMENT AND OUTCOMES FOR PATIENTS WITH PULMONARY EPITHELIOID HEMANGIOENDOTHELIOMA | Deven Patel | 13:40~13:50 | OP2-07 |
| FP-0073 | Others | USEFULNESS OF PULMONARY REHABILITATION IN NON-SMALL CELL LUNG CANCER BY ANALYZING PULMONARY FUNCTION TEST AND CHEST COMPUTED TOMOGRAPHY | Juwhan Choi | 13:50~14:00 | OP2-08 |
| FP-0040 | Others | USING PATIENT-REPORTED OUTCOMES TO MANAGE POSTOPERATIVE SYMPTOMS IN PATIENTS WITH LUNG CANCER: A MULTICENTER, RANDOMISED CONTROLLED TRIAL | Wei Dai | 14:00~14:10 | OP2-09 |
| FP-0065 | Radiotherapy | ANALYSIS OF DOSIMETRIC FACTORS ASSOCIATED WITH RADIATION PNEUMONITIS IN PATIENTS WITH NON-SMALL-CELL LUNG CANCER TREATED WITH CONCURRENT CHEMORADIOTHERAPY FOLLOWED BY IMMUNOTHERAPY | Jeong Yun Jang | 14:30~14:40 | OP3-01 |
| FP-0047 | Radiotherapy | PROTON THERAPY REDUCED THE LIKELIHOOD OF SEVERE RADIATION-INDUCED LYMPHOPENIA IN LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER: COMPARATIVE STUDY OF PROTON VS PHOTON | Nalee Kim | 14:40~14:50 | OP3-02 |
| FP-0027 | Radiotherapy | RADIATION TO PRIMARY LESIONS IN PATIENTS WITH NON-OLIGOMETASTATIC NON-SMALL CELL LUNG CANCER WITH EGFR MUTATION WHO DO NOT PROGRESS AFTER TKI , RESULTS OF A PHASE II STUDY | Qifeng Wang | 14:50~15:00 | OP3-03 |
| FP-0066 | Early / Locally Advanced NSCLC | PREDICTION OF DELAYED LYMPHOPENIA AT THE TIME OF CONSOLIDATION IMMUNOTHERAPY AFTER CHEMORADIOTHERAPY IN LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER | Byung-Hee Kang | 15:00~15:10 | OP3-04 |
| FP-0042 | Surgery | INTRAOPERATIVE ELECTROMAGNETIC NAVIGATION WITH PERCUTANEOUS LOCALIZATION (EMPL) FOR PULMONARY NODULES | Stephanie Cerrone | 15:10~15:20 | OP3-05 |
| FP-0039 | Surgery | THE PATIENT-CLINICIAN DISCREPANCY OF PERCEPTION ON SYMPTOMS AFTER LUNG CANCER SURGERY FOR PATIENTS | Xing Wei | 15:20~15:30 | OP3-06 |
| FP-0038 | Surgery | EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) MUTATION STATUS AFFECTS THE DYNAMIC PATTERN OF SITE-SPECIFIC RECURRENCE IN CURATIVELY RESECTED LUNG ADENOCARCINOMA PATIENTS | Xianping Liu | 15:30~15:40 | OP3-07 |
| FP-0049 | Surgery | NOVEL 3-DIMENSIONAL IMAGE SIMULATION FOR THORACOSCOPIC LUNG SEGMENTECTOMY IN PATIENTS WITH PULMONARY MALIGNANCY | Kenshiro Omura | 15:40~15:50 | OP3-08 |
| FP-0036 | Surgery | COMPARING OF MICROCOIL LOCALIZATION AND HOOK WIRE LOCALIZATION FOR RESECTABLE PULMONARY SMALL NODULES: A PROSPECTIVE CONTROLLED STUDY | Xizhao Sui | 15:50~16:00 | OP3-09 |
| FP-0072 | Early / Locally Advanced NSCLC | TARGETED NGS APPLICATION TO EVALUATE RECURRENT IMPACT IN RESECTED EGFR-MUTATED LUNG ADENOCARCINOMA | In Ae Kim | 16:00~16:10 | OP3-10 |
| Apply No. |
Final No. |
Category | Title | Presenting Author |
|---|---|---|---|---|
| FP-0059 | P-01 | Advanced NSCLC | DIAGNOSTIC AND PREDICTIVE VALUES OF 18F-FDG PET/CT METABOLIC PARAMETERS IN EGFR-MUTATED ADVANCED LUNG ADENOCARCINOMA | Seung Hyeun Lee |
| FP-0041 | P-02 | Advanced NSCLC | WHO WILL MAINTAIN AS LONG-TERM RESPONDERS MORE THAN 3 YEARS WITH FIRST- OR SECOND-GENERATION EGFR TKI AMONG EGFR MUTANT NSCLC? | Ja Hyun Yeo |
| FP-0024 | P-03 | Advanced NSCLC / Chemotherapy / Targeted Therapy / Immunotherapy | PEMBROLIZUMAB IN PRE-TREATED ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS (PTS): IMPACT OF BLOOD-BASED BIOMARKERS ON SURVIVAL OUTCOMES | Ana Ortega Franco |
| FP-0060 | P-04 | Advanced NSCLC / Chemotherapy / Targeted Therapy / Immunotherapy | PRIMARY RESISTANCE TO IMMUNE CHECKPOINT BLOCKADE IN AN STK11/TP53/KRAS-MUTANT LUNG ADENOCARCINOMA WITH HIGH PD-L1 EXPRESSION | Seung Hyeun Lee |
| FP-0058 | P-05 | Advanced NSCLC / Chemotherapy / Targeted Therapy / Immunotherapy | ACQUIRED RESISTANCE MECHANISM OF EGFR-KDD AGAINST EGFR TKIS IN NSCLC | Chaelin Lee |
| FP-0056 | P-06 | Advanced NSCLC / Chemotherapy / Targeted Therapy / Immunotherapy | LXH254 IN COMBINATION WITH AURKA INHIBITORS IS EFFECTIVE AGAINST NRAS-MUTANT NON-SMALL CELL LUNG CANCER (NSCLC) CELLS | Siyeon Park |
| FP-0051 | P-07 | Advanced NSCLC / Chemotherapy / Targeted Therapy / Immunotherapy | FIRST-LINE (1L) NIVOLUMAB + IPILIMUMAB IN ASIAN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (ANSCLC) IN CHECKMATE 227 | Jong-Seok Lee |
| FP-0050 | P-08 | Advanced NSCLC / Chemotherapy / Targeted Therapy / Immunotherapy | THE CONTRADICTION OF EGFR MUTATIONS BETWEEN MEN AND WOMEN IN INDONESIA : LITERATURE REVIEWS | Fikri Gemilang |
| FP-0030 | P-09 | Advanced NSCLC / Chemotherapy / Targeted Therapy / Immunotherapy | COMPREHENSIVE EVALUATION OF THE CLINICAL UTILITY OF PLASMA EGFR TEST IN NON-SMALL CELL LUNG CANCER PATIENTS WITH ACQUIRED RESISTANCE TO FIRST-LINE EGFR INHIBITORS | Hongsik Kim |
| FP-0026 | P-10 | Advanced NSCLC / Chemotherapy / Targeted Therapy / Immunotherapy | CONSOLIDATIVE HIGH-DOSE RADIOTHERAPY FOR OLIGOMETASTATIC NON-SMALL CELL LUNG CANCER | Hakyoung Kim |
| FP-0082 | P-11 | Basic & Translational Research / Biology / Pathology | LUNG CANCER IN THE PREGNANT WOMAN: TO TREAT OR NOT TO TREAT, THAT IS THE QUESTION | Ramlah Ramlah |
| FP-0078 | P-12 | Basic & Translational Research / Biology / Pathology | A RARE CASE OF LUNG ADENOCARCINOMA HARBORING V600 DELETION MUTATION | Heae Surng Park |
| FP-0067 | P-13 | Basic & Translational Research / Biology / Pathology | CYTOKINE PROFILE OF EGFR WILD AND MUTANT TYPE LUNG ADENOCARCINOMA CELL LINES AFTER DIFFERENT RADIATION DOSES. | Yun Hee Lee |
| FP-0054 | P-14 | Basic & Translational Research / Biology / Pathology | OVERCOMING ACQUIRED RESISTANCE TO EGFR INHIBITOR THROUGH MODULATION OF ERK | Bo Mi Ku |
| FP-0053 | P-15 | Basic & Translational Research / Biology / Pathology | TUMOR-ASSOCIATED IMMUNE CELL PROFILING REVEALS DISTINCT IMMUNE CHECKPOINT INHIBITOR OUTCOMES IN ADVANCED NON-SMALL CELL LUNG CANCER | Bo Mi Ku |
| FP-0025 | P-16 | Basic & Translational Research / Biology / Pathology | IMPACT OF PRE-TREATMENT AXL EXPRESSION ON EGFR-TKI EFFICACY IN PATIENTS WITH NON-SMALL CELL LUNG CANCER WITH EGFR MUTATION | Akihiro Yoshimura |
| FP-0016 | P-17 | Basic & Translational Research / Biology / Pathology | DIAGNOSTIC EGFR MUTATIONS IN NON SMALL CELL LUNG CANCER WITH SPECIMENS OF BODY CAVITY FLUIDS | Lam Nguyen Son |
| FP-0079 | P-18 | Chemotherapy / Targeted Therapy / Immunotherapy / Advanced NSCLC | ANALYSIS OF THE IMPACT OF CHEMOTHERAPY IN LUNG CANCER PATIENTS IN INDONESIA: LITERATURE REVIEW | Rahmat Fauzan |
| FP-0057 | P-19 | Chemotherapy / Targeted Therapy / Immunotherapy / Advanced NSCLC | ACQUIRED RESISTANCE MECHANISMS OF OSIMERTINIB IN PATIENTS WITH DE NOVO EGFRT790M-MUTANT NON-SMALL CELL LUNG CANCER (NSCLC) | Ha-Ram Park |
| FP-0043 | P-20 | Chemotherapy / Targeted Therapy / Immunotherapy / Advanced NSCLC | LUNG CANCER IN INDONESIA: HOW INDONESIA MEDICAL SCIENCES FIGHT WITH THIS ISSUE? | Zulfa Saumia |
| FP-0034 | P-21 | Chemotherapy / Targeted Therapy / Immunotherapy / Advanced NSCLC | IN VITRO ANTICANCER ACTIVITY OF ANDROGRAPHOLIDE DERIVATIVES IN NSCLC CELL LINES WITH VARIOUS K-RAS STATUS | Amir Imran |
| FP-0071 | P-22 | Early / Locally Advanced NSCLC | GENETIC VARIANT OF BRD3 PREDICTS SURVIVAL OUTCOME AFTER SURGERY FOR NON-SMALL CELL LUNG CANCER | Seung Soo Yoo |
| FP-0017 | P-23 | Mesothelioma / Thymic & Other Thoracic Malignancies | EXPRESSIONS OF BIOMARKERS OF MALIGNANT PLEURAL MESOTHELIOMA AT PHAM NGOC THACH HOSPITAL, VIETNAM IN 5 YEARS FROM 2015-2019 | Lam Nguyen Son |
| FP-0077 | P-24 | Palliative Care | EFFECT PALLIATIVE CARE ON QUALITY OF LIFE FOR LUNG CANCER PATIENTS: A LITERATURE OF REVIEW | Putri Ayu |
| FP-0084 | P-25 | Pulmonology / Endoscopy | PREDICTION OF DELAYED PNEUMOTHORAX USING LUNG ULTRASOUND AFTER TRANSTHORACIC NEEDLE BIOPSY | Jeong Suk Koh |
| FP-0083 | P-26 | Radiology / Staging / Screening / Epidemiology | RISK FACTORS FOR PRIMARY LUNG CANCER AMONG NON-SMOKING WOMEN | Nuraliah Nuraliah |
| FP-0046 | P-27 | Radiology / Staging / Screening / Epidemiology | APPLICATION OF THE N DESCRIPTORS PROPOSED BY THE INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER IN CLINICAL STAGING | Hwayoung Song |
| FP-0021 | P-28 | Radiology / Staging / Screening / Epidemiology | COLLATERAL EFFECTS OF THE CORONAVIRUS DISEASE 2019 PANDEMIC ON LUNG CANCER DIAGNOSIS IN KOREA | Ji Young Park |
| FP-0063 | P-29 | Radiotherapy | DOSE-ESCALATED RADIOTHERAPY FOR LIMITED-DISEASE SMALL CELL LUNG CANCER | Eun Yeong Yang |
| FP-0052 | P-30 | Radiotherapy | PROSPECTIVE STUDY OF HYPOFRACTIONATED PROTON THERAPY FOR INOPERABLE EARLY STAGE LUNG CANCER; PRELIMINARY RESULTS. | Heejoo Park |
| FP-0044 | P-31 | Radiotherapy | SALVAGE PROTON BEAM THERAPY FOR LOCOREGIONAL RECURRENCE OF NON-SMALL CELL LUNG CANCER | Hyunju Shin |
| FP-0035 | P-32 | Radiotherapy | HOW TO MANAGE RADIOTHERAPHY DURING COVID19 PANDEMIC? | Fitri Kurnia |
| FP-0033 | P-33 | Radiotherapy | UPDATED RESULTS OF MODERATE-INTENSITY STEREOTACTIC BODY RADIATION THERAPY FOR ULTRA-CENTRAL LUNG TUMOR | Sunmin Park |
| FP-0068 | P-34 | SCLC / Neuroendocrine Tumors | IMPACT OF IMMUNE CHECKPOINT GENE CD155 ALA67THR AND CD226 GLY307SER POLYMORPHISMS ON SMALL CELL LUNG CANCER CLINICAL OUTCOME | Seung Soo Yoo |
| FP-0015 | P-35 | Others | A CROSS-SECTIONAL STUDY ON TOBACCO CONSUMPTION PATTERN AMONG AUTO RICKSHAW DRIVERS IN CHENNAI CITY, TAMIL NADU, INDIA | Delfin Lovelina Francis |
| FP-0076 | P-36 | Others | ANALYSIS RISK FACTORS AND CONSEQUENCES TOWARD LUNG CANCER DISEASE IN INDONESIA | Anna Farhana |